1.02
price up icon3.03%   0.03
after-market After Hours: 1.04 0.02 +1.96%
loading

Clearside Biomedical Inc Stock (CLSD) Forecast

The Clearside Biomedical Inc (CLSD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.4715, representing a +44.27% increase from the current price of $1.02. The highest analyst price target is $1.9055, and the lowest is $1.0375.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLSD Price Target
Average 2.6191 (+156.77% Upside)
loading

Is Clearside Biomedical Inc (CLSD) A Buy Now?

Oscillators
Name Value Action
RSI(14) 41.53 Neutral
STOCH(9,6) 40.61 Neutral
STOCHRSI(14) 29.30 Neutral
MACD(12,26) -0.0382 Sell
ADX(14) 10.84 Neutral
William %R -75.96 Neutral
CCI(14) -85.58 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.074
Sell
1.0589
Sell
MA20
1.0755
Sell
1.0887
Sell
MA50
1.19
Sell
1.1339
Sell
MA100
1.1505
Sell
1.1633
Sell
MA200
1.2587
Sell
1.1632
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, CLSD could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on CLSD, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 41.53 indicates that CLSD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 40.61 indicates that CLSD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 29.3 indicates that CLSD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 10.84 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -85.58 indicates that CLSD is still oversold but not to an extreme extent.

Long-term CLSD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Clearside Biomedical Inc financial reports and earnings history, Clearside Biomedical Inc (CLSD) stock could reach $1.46 by 2030, $1.716 by 2040 and $3.2383 by 2050. See the projected annual prices until 2050 of the Clearside Biomedical Inc stock below:

  • Clearside Biomedical Inc (CLSD) is expected to reach an average price of $1.1685 in 2035, with a high prediction of $1.3485 and a low estimate of $0.8434. This indicates an $14.56% rise from the last recorded price of $1.02.
  • Clearside Biomedical Inc (CLSD) stock is projected to chart a bullish course in 2040, with an average price target of $1.2461, representing an $22.17% surge from its current level. The forecast ranges from a conservative $1.1479 to a sky-high $1.716.
  • Our analysts predict Clearside Biomedical Inc (CLSD) to jump 62.03% by 2045, soaring from $1.3127 to an average price of $1.6527, potentially reaching $1.7327. While $1.3127 is the low estimate, the potential upside is significant.
  • Clearside Biomedical Inc (CLSD) stock is expected to climb by 2050, reaching an average of $3.0083, a $194.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.2383 and $1.6982, respectively, highlighting the market's uncertainty.

Clearside Biomedical Inc Stock (CLSD) Year by Year Forecast

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2024

Our forecast for CLSD stock price in 2024 now indicates an average price target of $1.3796 with a high forecast of $2.12 and a low forecast of $0.6393. The average prediction reflects an increase of +35.26% from the last recorded price of $1.02.
Month Average Low High Change from today's price
December, 2024 $1.7355 $1.0375 $1.9055 +70.15%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2025

Clearside Biomedical Inc Stock (CLSD) is expected to reach an average price of $2.6883 in 2025, with a high prediction of $4.2007 and a low estimate of $1.1759. This indicates an +163.56% rise from the last recorded price of $1.02.
Month Average Low High Change from today's price
January, 2025 $1.9706 $1.5955 $4.0256 +93.20%
February, 2025 $3.8757 $1.8756 $3.9957 +279.97%
March, 2025 $2.2557 $1.9857 $4.2007 +121.15%
April, 2025 $1.7557 $1.1759 $3.3758 +72.13%
May, 2025 $2.2287 $1.5356 $2.6159 +118.50%
June, 2025 $2.0559 $1.8447 $2.4259 +101.56%
July, 2025 $2.046 $1.886 $2.626 +100.59%
August, 2025 $1.8161 $1.7361 $2.1361 +78.05%
September, 2025 $1.8362 $1.6661 $2.1261 +80.01%
October, 2025 $1.6262 $1.5662 $2.0162 +59.43%
November, 2025 $1.6163 $1.5063 $1.9163 +58.46%
December, 2025 $1.4264 $1.3264 $1.6763 +39.84%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2026

The predicted value for Clearside Biomedical Inc (CLSD) in 2026 is set at an average of $4.5768. Estimates vary from a peak of $7.8071 to a trough of $1.3464, indicating an +348.70% surge from the present price of $1.02.
Month Average Low High Change from today's price
January, 2026 $2.0264 $1.3464 $2.1564 +98.67%
February, 2026 $2.1165 $1.7565 $2.4765 +107.50%
March, 2026 $4.0866 $1.9965 $4.3766 +300.64%
April, 2026 $3.9266 $3.0466 $4.6066 +284.97%
May, 2026 $2.8167 $2.7367 $4.3267 +176.15%
June, 2026 $2.7368 $2.2867 $2.8767 +168.31%
July, 2026 $2.4569 $2.3369 $3.3768 +140.87%
August, 2026 $3.0869 $2.3069 $3.3469 +202.64%
September, 2026 $5.587 $3.0869 $7.367 +447.75%
October, 2026 $5.2871 $4.647 $6.207 +418.34%
November, 2026 $6.9671 $4.9371 $7.8071 +583.05%
December, 2026 $6.0572 $5.8772 $7.4172 +493.84%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Clearside Biomedical Inc (CLSD) is $3.8175, with a high forecast of $6.2971 and a low forecast of $1.3379. This indicates an +274.27% increase from the last price of $1.02.
Month Average Low High Change from today's price
January, 2027 $5.8073 $4.8972 $6.2971 +469.34%
February, 2027 $4.4473 $4.4273 $6.1973 +336.01%
March, 2027 $3.0174 $2.7474 $4.4774 +195.83%
April, 2027 $2.3075 $2.2475 $3.0874 +126.22%
May, 2027 $1.8675 $1.7775 $2.3475 +83.09%
June, 2027 $1.4676 $1.4076 $1.9286 +43.88%
July, 2027 $2.3677 $1.3876 $2.9277 +132.13%
August, 2027 $1.6778 $1.6578 $2.6177 +64.49%
September, 2027 $1.4178 $1.3478 $1.9578 +39.00%
October, 2027 $1.5379 $1.3379 $1.5779 +50.77%
November, 2027 $1.808 $1.448 $1.808 +77.25%
December, 2027 $1.668 $1.518 $1.933 +63.53%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2028

In 2028, Clearside Biomedical Inc (CLSD) is projected to reach an average price of $1.4536, with a high projection of $1.9285 and a low estimate of $0.9787. This indicates an +42.51% rise from the last price of $1.02.
Month Average Low High Change from today's price
January, 2028 $1.4381 $1.3881 $1.6781 +40.99%
February, 2028 $1.2082 $1.0782 $1.4681 +18.45%
March, 2028 $1.2183 $1.0982 $1.4982 +19.44%
April, 2028 $1.2583 $1.1883 $1.6883 +23.36%
May, 2028 $1.2184 $1.0584 $1.3584 +19.45%
June, 2028 $1.5785 $1.1184 $1.8984 +54.75%
July, 2028 $1.3985 $1.361 $1.9285 +37.11%
August, 2028 $1.1586 $1.1386 $1.4986 +13.59%
September, 2028 $1.3187 $0.9787 $1.5587 +29.28%
October, 2028 $1.0887 $0.9905 $1.3287 +6.74%
November, 2028 $1.2288 $1.0788 $1.2687 +20.47%
December, 2028 $1.1989 $1.1789 $1.6189 +17.54%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2029

The 2029 price forecast for Clearside Biomedical Inc Stock (CLSD) is $1.4644 on average, with a high prediction of $2.1996 and a low estimate of $0.7293. This represents an +43.57% increase from the previous price of $1.02.
Month Average Low High Change from today's price
January, 2029 $1.249 $1.1089 $1.3788 +22.45%
February, 2029 $1.019 $0.999 $1.269 -0.10%
March, 2029 $0.9041 $0.9041 $1.039 -11.36%
April, 2029 $0.9401 $0.8991 $0.9891 -7.83%
May, 2029 $1.0475 $0.7293 $1.2692 +2.70%
June, 2029 $1.1093 $0.9578 $1.1393 +8.75%
July, 2029 $1.2494 $1.0036 $1.3393 +22.49%
August, 2029 $1.3294 $1.1794 $1.6144 +30.34%
September, 2029 $1.4395 $1.2495 $1.5395 +41.13%
October, 2029 $1.7896 $1.3795 $2.1996 +75.45%
November, 2029 $1.3896 $1.1796 $1.8596 +36.24%
December, 2029 $1.345 $1.31 $1.5597 +31.86%

Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2030

Clearside Biomedical Inc Stock (CLSD) is expected to reach an average price of $2.4955 in 2030, with a high forecast of $4.2764 and a low forecast of $0.7145. This signifies an +144.65% surge from the last price of $1.02.
Month Average Low High Change from today's price
January, 2030 $1.1952 $1.1026 $1.46 +17.17%
February, 2030 $1.3503 $1.1103 $1.3703 +32.38%
March, 2030 $1.2154 $1.2004 $1.3503 +19.16%
April, 2030 $0.7572 $0.7145 $1.5404 -25.76%
May, 2030 $0.7807 $0.7206 $1.0956 -23.46%
June, 2030 $1.0758 $0.7507 $1.2108 +5.47%
July, 2030 $1.301 $1.0758 $1.5315 +27.55%
August, 2030 $2.5611 $1.3113 $3.0011 +151.09%
September, 2030 $2.3613 $1.9334 $4.1012 +131.50%
October, 2030 $2.6564 $2.1013 $4.2764 +160.43%
November, 2030 $2.1415 $1.9218 $3.4515 +109.95%
December, 2030 $1.7217 $1.2517 $2.1216 +68.79%
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Cap:     |  Volume (24h):